TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 8 | 0 | -1 | -1 | 1 | -0 | 7 | 1 |
| S | %wins | 63 | 50 | 63 | 50 | 38 | 50 | 52 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/15 16:38 | 8/10/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -3,346 | 130.82 | 33 | -26 | -28 | 65 | D | 84 | 50 | 9 | 15 | 13 | -5 | 0 | 2 | -1 | -1 | -6 | -13 | -21 | -14 |
7/29/15 16:29 | 7/28/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -3,981 | 133.96 | 33 | -30 | -31 | 65 | D | 88 | 55 | 11 | 19 | 22 | 17 | 1 | -3 | 0 | -1 | -10 | -6 | -22 | -18 |
7/15/15 16:30 | 7/13/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -3,642 | 120.78 | 33 | -30 | -34 | 59 | D | 83 | 39 | 5 | 6 | 8 | 2 | 3 | 5 | 2 | 4 | 0 | -11 | -20 | -24 |
12/17/14 16:03 | 12/15/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -3,452 | 115.06 | 33 | -30 | -38 | 48 | D | 177 | 35 | 37 | 19 | 4 | -1 | -4 | -6 | 3 | -6 | 8 | 11 | 4 | 3 |
11/26/14 16:32 | 11/24/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -3,729 | 110.27 | 33 | -34 | -41 | 48 | D | 182 | 35 | 45 | 17 | 28 | 6 | 7 | 3 | 1 | 1 | 1 | 8 | 2 | 0 |
2/11/14 16:25 | 2/7/14 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -4,622 | 156.00 | 33 | -30 | -59 | 20 | D | 113 | 56 | 10 | 8 | -7 | -7 | 2 | 4 | 0 | 4 | -1 | -6 | 9 | 51 |
8/29/13 21:08 | 8/28/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -4,422 | 137.06 | 33 | -32 | -66 | 17 | D | 147 | 93 | 35 | 12 | 5 | -2 | 5 | 1 | -2 | 2 | 9 | 15 | 13 | 34 |
5/30/13 17:31 | 5/28/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Daniel Thomas O | NJ | O | see rema | S.d | -4,117 | 124.91 | 33 | -33 | -85 | 6 | D | 109 | 76 | 56 | 22 | 1 | 0 | -1 | 0 | -1 | -10 | -5 | 10 | 32 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |